The efficacy and safety of anti-vascular endothelial growth factor combined with Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma: a systematic review and meta-analysis.

Front Med (Lausanne) · 2024 · PMC11323747 · PMID 39144652

Europe PMC DOI

hedged sentence

0.2600

closest p · 5.2× alpha

0.2600

boldest claim

The sentences

did not reach statistical significancep = 0.260not close (p > 0.1)

Nevertheless, it is important to mention that the outcomes of bevacizumab group did not reach statistical significance ( p = 0.260) ( Figure 4B ). 3.4.5 IOP more than 12 months postoperatively Four RCTs ( 27 – 29 , 33 ), comprising 209 eyes, investigated the effects of combined AGVI with anti-VEGF drugs versus AGVI alone on IOP more than 12 months postoperatively.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.